Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Christine Bialonczyk"'
Autor:
Sabine Eichinger, Paul A. Kyrle, Christine Bialonczyk, Gregor Hron, Marietta Kollars, Erich Minar, Mirko Hirschl
Publikováno v:
Thrombosis and Haemostasis. 98:1232-1236
SummaryIn patients with venous thromboembolism (VTE) a laboratory assay that globally measures the overall thrombophilic tendency is not available. We hypothesized that determination of ProC® Global, a plasma assay which tests the global function of
Autor:
M. Hirschl, Erich Minar, Christine Mannhalter, Christine Bialonczyk, V. Schönauer, M. Funk, R. Vormittag, Ingrid Pabinger, T. Vukovich
Publikováno v:
Atherosclerosis. 188:406-411
Objective Data on C-reactive protein (CRP) as a risk indicator of venous thromboembolism are conflicting. A recent study reported higher CRP levels in homozygous carriers of a novel CRP gene polymorphism at the 3′ UTR (CRP +1444C>T). We investigate
Autor:
Ingrid Pabinger, Erich Minar, Alexandra Kaider, Christine Bialonczyk, Mirko Hirschl, Kety Hsieh, Rainer Vormittag, Christine Mannhalter
Publikováno v:
Thrombosis and Haemostasis. 95:802-806
SummaryIncreased levels of interleukin-6 (IL-6) have been reported in patients with a history of venous thromboembolism (VTE); however, prospective studies did not confirm an association between inflammatory markers that are highly correlated with IL
Autor:
Paul Knöbl, Kety Hsieh, Hugo Partsch, Klaus Lechner, Paul A. Kyrle, C. Rintelen, Ingrid Pabinger, Peter Quehenberger, Christine Bialonczyk
Publikováno v:
British Journal of Haematology. 123:490-495
Anti-beta2-glycoprotein I (beta2GPI) antibodies are frequently found in patients with lupus anticoagulant (LA). To investigate the prevalence of antibeta2GPI antibodies and their clinical impact in patients with a history of venous thromboembolism (V
Autor:
Hugo Partsch, Peter Quehenberger, Verena Schönauer, Erich Minar, Mirko Hirschl, Paul A. Kyrle, Barbara Schneider, Sabine Eichinger, Ansgar Weltermann, Christine Bialonczyk
Publikováno v:
Journal of Vascular Surgery. 37(4):834-838
Objective: Superficial thrombophlebitis (ST) is a frequent and potentially serious disease if complicated with venous thromboembolism (VTE). Data on risk factors and incidence rates for ST are scarce. It is also unknown whether ST is a risk factor fo
Autor:
Mirko Hirschl, Peter Quehenberger, V. Schönauer, Christine Bialonczyk, Sabine Eichinger, A. Weltermann, Paul A. Kyrle, Erich Minar
Publikováno v:
Journal of Thrombosis and Haemostasis. 1:28-32
Summary. High factor IX (FIX) is a risk factor of deep vein thrombosis. The impact of high FIX on the risk of recurrent venous thrombosis is unknown. We prospectively followed 546 patients after anticoagulation for a first spontaneous venous thromboe
Autor:
Milena Stain, Paul A. Kyrle, Klaus Lechner, Andreas Stümpflen, Christine Bialonczyk, Christine Mannhalter, Barbara Schneider, Erich Minar, Mirko Hirschl, S. Eichinger
Publikováno v:
Scopus-Elsevier
SummaryA G20210A transition in the prothrombin gene is a common risk factor of venous thrombosis. The risk of recurrent venous thrombo-embolism in carriers of the 20210A allele is unknown and guidelines for secondary thromboprophylaxis in these patie
Autor:
Rainer, Vormittag, Kety, Hsieh, Alexandra, Kaider, Erich, Minar, Christine, Bialonczyk, Mirko, Hirschl, Christine, Mannhalter, Ingrid, Pabinger
Publikováno v:
Thrombosis and haemostasis. 95(5)
Increased levels of interleukin-6 (IL-6) have been reported in patients with a history of venous thromboembolism (VTE); however, prospective studies did not confirm an association between inflammatory markers that are highly correlated with IL-6 and
Autor:
Mirko Hirschl, Erich Minar, Milena Stain, Sabine Eichinger, Paul A. Kyrle, Christine Bialonczyk, V. Schönauer, A. Weltermann
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 3(12)
Summary. Background: The post-thrombotic syndrome (PTS) is a frequent complication of deep vein thrombosis (DVT). Patients with recurrent ipsilateral DVT have an increased risk of PTS; other risk factors are unknown. Objectives: To establish risk fac
Autor:
Rainer, Vormittag, Thomas, Vukovich, Christine, Mannhalter, Erich, Minar, Verena, Schönauer, Christine, Bialonczyk, Mirko, Hirschl, Ingrid, Pabinger
Publikováno v:
Haematologica. 90(11)
Haptoglobin (Hp) is a plasma protein that binds free hemoglobin and thus prevents catalysis of reactive oxygen species by the Fenton reaction. A genetic polymorphism has been described that leads to the generation of two distinct alleles, Hp1 and Hp2